methylphenidate : Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) - PSUSA/00002024/202110
(PDF/126.49 KB)
(new)
Last updated: 05/08/2022
Active substance: methylphenidate
Procedure number: PSUSA/00002024/202110
Regulatory outcome: Variation